Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA antigens in multiple sclerosis.

E Thorsby, A Helgesen, B G Solheim

    Journal of the Neurological Sciences
    |June 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ABO identical versus ABO compatible plasma transfusions.

    Vox sanguinis·2012
    Same author

    MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro.

    European journal of neurology·2009
    Same author

    GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.

    European journal of neurology·2008
    Same author

    Transfussion-related acute lung unjury (TRALI)--the preventable danger in intensive care?

    Intensive care medicine·2007
    Same author

    Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.

    Vox sanguinis·2007
    Same author

    Measures to prevent TRALI.

    Vox sanguinis·2007
    Same journal

    Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

    Journal of the neurological sciences·2026
    Same journal

    Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

    Journal of the neurological sciences·2026
    Same journal

    Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

    Journal of the neurological sciences·2026
    Same journal

    Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

    Journal of the neurological sciences·2026
    Same journal

    Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

    Journal of the neurological sciences·2026
    Same journal

    Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

    Journal of the neurological sciences·2026
    See all related articles

    The human leukocyte antigen (HLA)-Dw2 determinant was significantly more frequent in multiple sclerosis patients (68%) than in healthy individuals (30.2%). This finding suggests a potential link between HLA-Dw2 and multiple sclerosis susceptibility.

    Area of Science:

    • Immunogenetics
    • Neurology
    • Autoimmune Diseases

    Background:

    • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
    • Genetic factors, particularly human leukocyte antigen (HLA) genes, are implicated in MS susceptibility.
    • Previous studies have suggested associations between specific HLA types and MS, but further investigation is warranted.

    Purpose of the Study:

    • To investigate the association between the HLA-Dw2 determinant and multiple sclerosis (MS).
    • To compare the frequency of HLA-Dw2 in MS patients versus healthy controls.
    • To explore potential correlations with other immune markers and viral antibody presence in the central nervous system (CNS).

    Main Methods:

    • Case-control study comparing HLA-Dw2 frequencies.

    Related Experiment Videos

  • Analysis of 37 patients with long-standing multiple sclerosis and a control group of healthy individuals.
  • Assessment of associations with B cell specificity (SOW) and HLA-B7.
  • Evaluation of correlation with oligoclonal IgG and viral antibodies (measles, rubella) in CNS.

    • Main Results:

    • The frequency of the HLA-Dw2 determinant was significantly higher in MS patients (68%) compared to healthy controls (30.2%).
    • A strong association was also observed with the "Ia-like" B cell specificity, SOW.
    • The association with HLA-B7 was less pronounced, and no correlation was found between HLA-Dw2 and local CNS immune responses (oligoclonal IgG, viral antibodies).

    Conclusions:

    • The HLA-Dw2 determinant shows a significant association with multiple sclerosis.
    • The findings suggest a potential role for HLA-Dw2 in MS pathogenesis.
    • Further research is needed to elucidate the specific mechanisms underlying this association and its relationship with other immune factors.